Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedNov 24, 2025
DataAggregated Company Financials
Companies15
  • 7D1.1%
  • 3M15.7%
  • 1Y26.5%
  • YTD25.1%

In the last week, the Pharma industry is up 1.1%, with AstraZeneca up 1.7%. This means that the industry has gained 26% over the past year. Earnings are forecast to grow by 12% annually.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 24 Nov 2025UK£325.5bUK£90.6bUK£14.8b22.1x22x3.6x
Wed, 22 Oct 2025UK£298.0bUK£87.9bUK£11.7b20.4x25.4x3.4x
Fri, 19 Sep 2025UK£270.5bUK£87.3bUK£11.7b20.4x23.2x3.1x
Sun, 17 Aug 2025UK£275.2bUK£87.3bUK£11.7b21.9x23.6x3.2x
Tue, 15 Jul 2025UK£262.7bUK£86.7bUK£10.7b25.5x24.7x3x
Thu, 12 Jun 2025UK£273.8bUK£86.3bUK£10.6b27.2x25.8x3.2x
Sat, 10 May 2025UK£258.5bUK£87.2bUK£10.7b26.3x24.2x3x
Mon, 07 Apr 2025UK£266.5bUK£87.9bUK£9.7b30.7x27.4x3x
Wed, 05 Mar 2025UK£294.1bUK£88.4bUK£9.7b29.9x30.3x3.3x
Fri, 31 Jan 2025UK£239.2bUK£75.8bUK£7.8b33.6x30.6x3.2x
Sun, 29 Dec 2024UK£224.3bUK£75.3bUK£7.8b31.4x28.9x3x
Tue, 26 Nov 2024UK£225.0bUK£75.4bUK£7.8b31.4x28.9x3x
Thu, 24 Oct 2024UK£250.5bUK£72.7bUK£9.1b30.3x27.6x3.4x
Sat, 21 Sep 2024UK£252.7bUK£71.5bUK£8.9b37.8x28.3x3.5x
Mon, 19 Aug 2024UK£275.1bUK£72.6bUK£9.0b40.7x30.4x3.8x
Wed, 17 Jul 2024UK£256.4bUK£70.7bUK£9.4b35.1x27.2x3.6x
Fri, 14 Jun 2024UK£266.6bUK£71.3bUK£9.6b32x27.9x3.7x
Sun, 12 May 2024UK£273.5bUK£72.1bUK£9.6b37.4x28.4x3.8x
Tue, 09 Apr 2024UK£240.2bUK£70.7bUK£9.7b31.9x24.8x3.4x
Thu, 07 Mar 2024UK£234.3bUK£70.4bUK£9.7b30.5x24.1x3.3x
Sat, 03 Feb 2024UK£237.3bUK£69.8bUK£9.5b35.2x24.9x3.4x
Mon, 01 Jan 2024UK£235.0bUK£68.8bUK£10.7b35.5x22.1x3.4x
Wed, 29 Nov 2023UK£222.3bUK£68.9bUK£10.7b33.5x20.8x3.2x
Fri, 27 Oct 2023UK£234.7bUK£70.9bUK£10.4b54.2x22.6x3.3x
Sun, 24 Sep 2023UK£247.8bUK£70.5bUK£10.4b56.6x23.9x3.5x
Tue, 22 Aug 2023UK£234.0bUK£68.9bUK£10.2b53.5x23.1x3.4x
Thu, 20 Jul 2023UK£231.7bUK£67.2bUK£7.8b52x29.6x3.4x
Sat, 17 Jun 2023UK£251.8bUK£67.5bUK£7.9b55.5x32x3.7x
Mon, 15 May 2023UK£259.2bUK£68.6bUK£8.0b59.3x32.5x3.8x
Wed, 12 Apr 2023UK£253.2bUK£69.3bUK£6.9b53.5x36.9x3.7x
Fri, 10 Mar 2023UK£237.6bUK£70.9bUK£7.0b47.7x34x3.4x
Sun, 05 Feb 2023UK£236.0bUK£71.1bUK£6.3b38.1x37.2x3.3x
Tue, 03 Jan 2023UK£244.5bUK£80.2bUK£6.3b37.3x38.5x3x
Thu, 01 Dec 2022UK£240.0bUK£80.6bUK£6.4b37.2x37.7x3x
Price to Earnings Ratio

37.7x


Total Market Cap: UK£240.0bTotal Earnings: UK£6.4bTotal Revenue: UK£80.6bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 27.8x202320242025
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 22.0x which is lower than its 3-year average PE of 27.8x.
  • The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 33% per year over the last three years.
  • Revenues for these companies have grown 4.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market-1.42%
Healthcare1.05%
Pharma1.15%
Pharma1.15%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUK£138.201.7%
+UK£3.5b		31.9%PE29.9x
HLN HaleonUK£3.772.1%
+UK£685.8m		0.05%PE22.1x
AGY Allergy TherapeuticsUK£0.09310.0%
+UK£52.2m		87.0%PS10.3x
HIK Hikma PharmaceuticalsUK£15.951.1%
+UK£39.9m		-19.4%PE12.5x
EAH ECO Animal Health GroupUK£0.925.1%
+UK£3.0m		43.8%PE37x

Latest News

POLB
UK£0.036
Poolbeg Pharma
7D
-11.1%
1Y
-52.9%
AGY
UK£0.093
Allergy Therapeutics
7D
10.0%
1Y
87.0%
AZN
UK£138.20
AstraZeneca
7D
1.7%
1Y
31.9%
EAH
UK£0.92
ECO Animal Health Group
7D
5.1%
1Y
43.8%
NFX
UK£0.0031
Nuformix
7D
12.7%
1Y
468.8%
SAR
UK£0.13
Sareum Holdings
7D
-7.3%
1Y
-54.5%
HCM
UK£2.17
HUTCHMED (China)
7D
-5.2%
1Y
-23.0%

What You Can Learn From HUTCHMED (China) Limited's (LON:HCM) P/S

Nov 15
What You Can Learn From HUTCHMED (China) Limited's (LON:HCM) P/S
HLN
UK£3.77
Haleon
7D
2.1%
1Y
0.05%

Are Investors Undervaluing Haleon plc (LON:HLN) By 35%?

Nov 14
Are Investors Undervaluing Haleon plc (LON:HLN) By 35%?
GSK
UK£17.88
GSK
7D
-0.6%
1Y
32.8%

GSK: Margin Outlook and Digital Expansion Will Shape Performance Amid Industry Shifts

GSK's analyst price target has been raised from £14.00 to £15.00 per share. This change reflects analysts' updated expectations for higher fair value, improved growth prospects, and better profit margins supported by recent research commentary.
FUM
UK£0.012
Futura Medical
7D
-7.2%
1Y
-96.4%
HIK
UK£15.95
Hikma Pharmaceuticals
7D
1.1%
1Y
-19.4%

HIK: Shares Will Benefit From U S Approval And Profitability Improvements

Analysts have slightly reduced their fair value estimate for Hikma Pharmaceuticals from £25.40 to £23.55. This reflects modest downward adjustments to near-term price targets along with updated assumptions for discount rates, growth, and margins.
IMM
UK£0.098
ImmuPharma
7D
-2.2%
1Y
552.8%